Skip to content

Addiction Research & Theory

ISSN 1476-7392

4 papers in the library · 107 citations · publishing 2002-2018

Papers

Sort Most recent Most cited

Ceremonial ‘Plant Medicine’ use and its relationship to recreational drug use: an exploratory study

Addiction Research & Theory March 30, 2018 Caroline Dorsen, Joseph J Palamar, Michele G. Shedlin 21 citations

BACKGROUND: The ceremonial use of psychoactive/hallucinogenic plant based drugs, such as ayahuasca, psilocybin and others, is a growing trend in the United States (US) and globally. To date, there has been little research documenting how many people are using psychoactive substances in this context, who the users are, what benefits/risks exist in the use of these drugs and the relationship...

Buying Ayahuasca and other entheogens online: A word of caution

Addiction Research & Theory 2008 Phil Dalgarno 16 citations

Since the mid 1990's a number of publications have appeared in the UK and Europe and stimulated interest in a number of psychoactive plants native to South and Central America that had previously been relatively obscure outside of their places of origin. While information describing the effects of these together with extraction techniques was widely available, the plants themselves remained...

Reducing the risks of drug use: The case for set and setting

Addiction Research & Theory June 1, 2005 Phil Dalgarno, David Shewan 54 citations

The central proposition of this article is that if people are thoughtful, well-prepared and aware of the means and best environments for using a particular drug, then the risks associated with the use of a particular drug – any drug – can be minimal. The types of drugs discussed in this context focus on those assumed to be the most ‘addictive’ – heroin and cocaine – to those less well-known but...

Behavioral Psychopharmacology of MDMA and MDMA-Like Drugs: A Review of Human and Animal Studies

Addiction Research & Theory 2002 Diana L. Martinez-Price, Kirsten Krebs-Thomson, Mark A. Geyer 16 citations

Since being classified as a Schedule I controlled substance, MDMA (3,4-methylenedioxy-N-methylamphetamine; "ecstasy") has been the subject of controversy regarding its potential therapeutic usage, increased use by young people in the "Rave" culture, and issues of potential neurotoxicity. This review article summarizes much of the animal and human studies of the general behavioral effects of...